Novavax | NVAX - Ordinary Share Capital


Novavax reported $162.58M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Adma Biologics USD 232.29M 5.59M Mar/2026
Agenus USD 38.52M 3.2M Mar/2026
AstraZeneca USD 1.55B 44K Jun/2026
BioCryst Pharmaceuticals USD 255.26M 42.2M Jun/2026
Cassava Sciences USD 48.31M 0 Mar/2026
Geron USD 640.9M 2.54M Mar/2026
GlaxoSmithKline GBP 4.08B 20.6M Jun/2026
MannKind USD 309.91M 1M Jun/2026
Merck USD 2.47B 4.93M Mar/2026
Minerva Neurosciences USD 1000 0 Sep/2024
Moderna USD 391M 2M Sep/2025
Novartis USD 1.91B 60K Mar/2026
Novavax USD 162.58M 106K Dec/2025
Pfizer USD 5.7B 0 Jun/2026
Sanofi EUR 1.21B 8.25M Mar/2026
Sarepta Therapeutics USD 105.62M 53K Jun/2026
TG Therapeutics USD 153.08M 2.23M Jun/2026